WT1 and alveolar rhabdomyosarcoma: Ohta el al. [34] reported that WT1 peptide vaccination was effective in a pediatric patient with metastatic alveolar rhabdomyosarcoma who showed poor response to chemotherapy, and the patient had no adverse effects other than skin erythema.